Metastatic Brain

Metastatic Brain Article

Information resource about cancer clinical trials clinical trials to aid in the education and fight against melanoma interested in participating in clinical trials and for research professionals About Melanoma clinical trials listing About Melanoma Clinical Trials melanoma clinical trials from the clinical trials database at Mayo Clinic Mayo's clinical trials include experimental treatments, often unavailable Melanoma Clinical Trials at The University of Maryland Marlene and Stewart Greenebaum melanoma cancer centers,early detection of melanoma, melanoma clinical trials, A clinical trial search base for all trials Healthfinder System invites adults with melanoma to enroll in a research Cancer Center Clinical Trials melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical trials from the clinical trials database at Mayo Clinic Mayo's clinical trials include experimental treatments, often unavailable Melanoma Clinical Trials Cancer Information Cancer Center Home Cancer Care and Prevention Professionals Melanoma Trials All Cancer Clinical Trials Learn about the Metastatic Melanoma clinical trial at Novartis and see if you Clinical Trials at The University of Maryland Marlene and Stewart Greenebaum melanoma cancer centers,early detection of melanoma, melanoma clinical trials, A clinical trial search base for all trials Healthfinder System invites adults with melanoma to enroll in a research Cancer Center Clinical Trials for Melanoma

Metastatic Brain News

Usefulness of whole-body F-FDG PET in patients with suspected metastatic brain tumors

The aim of this study was to evaluate the diagnostic value of whole-body ^sup 18^F-FDG PET imaging in the differentiation of metastatic brain tumor from primary brain tumor and in the localization of the primary lesion in patients with metastatic brain tumor. Methods: The subjects consisted of 127

UNC-CH: UNC-CH to test new chemotherapy treatment for metastatic brain tumors

M2 PRESSWIRE-4 June 1998-UNC-CH: UNC-CH to test new chemotherapy treatment for metastatic brain tumors (C)1994-98 M2 COMMUNICATIONS LTD RDATE:030698 CHAPEL HILL - A drug-impregnated wafer that releases chemotherapy directly into brain tumors that have spread from other cancers is now undergoing

Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain.

Study Demonstrates Differentiation of Primary Tumors From Metastases in the Brain With Accuracy Near 90% Identifying Whether a Brain Malignancy is a Primary Tumor or a Metastasis is a Recurring Challenge for Pathologists Using Current Technologies Accurately Differentiating Primary From Metastatic

Utility of Tissue-Specific Transcription Factors Thyroid Transcription Factor 1 and Cdx2 in Determining the Primary Site of Metastatic Adenocarcinomas to the Brain

Context.-Brain metastases of adenocarcinoma of unknown primary pose a diagnostic dilemma to the surgical pathologist. Although the most common source in these cases is the lung, determining a primary source is difficult on routinely stained slides. Immunohistochemical stain panels including

Metastatic brain tumor targeted in new clinical trial; Alkermes expands testing of RMP-7 with Carboplatin.

CAMBRIDGE, MassBUSINESS WIREApril 22, 1996 - Alkermes, Inc. (NASDAQ:ALKS) today announced the initiation of a Phase I/II clinical trial of RMP-7 and the chemotherapeutic agent carboplatin administered intravenously in patients with metastatic brain tumor. The study is being conducted at two